Delta 9 Cannabis (CVE:NINE) Stock Price Up 3% – Should You Buy?

Delta 9 Cannabis Inc (CVE:NINEGet Free Report)’s stock price traded up 3% during mid-day trading on Wednesday . The company traded as high as C$1.13 and last traded at C$1.03. 68,728 shares changed hands during trading, a decline of 41% from the average daily volume of 117,300 shares. The stock had previously closed at C$1.00.

Delta 9 Cannabis Price Performance

The company has a quick ratio of 2.04, a current ratio of 4.44 and a debt-to-equity ratio of 33.00. The stock’s 50-day simple moving average is C$1.03 and its two-hundred day simple moving average is C$1.03. The company has a market capitalization of C$89.36 million and a price-to-earnings ratio of 19.07.

Delta 9 Cannabis Company Profile

(Get Free Report)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers. It also owns and operates retail cannabis store in Winnipeg, Manitoba, as well as cannabis superstore in Brandon, Manitoba. The company operates its retail stores under the Delta 9 Cannabis Store brand name.

Featured Stories

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.